Ventyx Biosciences to Participate in Three Upcoming Investor Conferences

Group 1 - Ventyx Biosciences is a clinical-stage biopharmaceutical company focused on developing novel oral therapies for inflammatory diseases with significant unmet medical needs [2] - The company has a pipeline that includes clinical programs targeting NLRP3, S1P1R, and TYK2, aiming to lead in oral immunology therapies for peripheral and neuroinflammatory diseases [2] - Ventyx will participate in several upcoming investor conferences, including the Stifel 2024 Healthcare Conference, Jefferies London Healthcare Conference, and Piper Sandler Healthcare Conference [1] Group 2 - The Stifel 2024 Healthcare Conference will take place on November 18, 2024, in New York, NY, from 4:10-4:40 PM ET [1] - The Jefferies London Healthcare Conference is scheduled for November 20, 2024, in London, UK, from 8:00-8:25 AM GMT [1] - The Piper Sandler Healthcare Conference will occur on December 4, 2024, in New York, NY, from 4:00-4:25 PM ET [1]